A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/1994
11/10/1994	WO1994025573A1 Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies
11/10/1994	WO1994025456A1 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- and/or 10-substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
11/10/1994	WO1994025437A1 N-acyl substituted phenyl piperidines as bronchodilators and anti-inflammatory agents
11/10/1994	WO1994025435A1 Peptidyl derivatives and their use as metalloproteinase inhibitors
11/10/1994	WO1994025431A1 Cyclooxygenase and 5-lipoxygenase inhibiting n(3-biphenylyl-1(s)-methyl-2-propenyl) acetohydroxamic acid derivatives
11/10/1994	WO1994025430A1 Cyclooxygenase and 5-lipoxygenase inhibiting hydroxamic acid derivatives
11/10/1994	WO1994025429A1 4-amino-fluorobenzamides and their use as cytotoxic prodrugs
11/10/1994	WO1994025052A1 Use of glutathione diesters
11/10/1994	WO1994025051A1 Thrombin inhibitors
11/10/1994	WO1994025049A1 Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes
11/10/1994	WO1994025047A1 Inhibition of leukocyte adhesion
11/10/1994	WO1994025046A1 Method of combating acyclovir-resistant herpes simplex viral infections
11/10/1994	WO1994025027A1 Btp receptor modulator of the gabaa/chloride channel complex for prolonging the duration of the gaba induced membrane current
11/10/1994	WO1994025016A1 Novel medical use for gaba agonists
11/10/1994	WO1994025007A1 Stable, ingestable and absorbable nadh and nadph therapeutic compositions
11/10/1994	WO1994021800A3 Protein tyrosine phosphatase ptp-s31
11/10/1994	WO1994021781A3 Extracellular signal-regulated kinase, sequences, and methods of production and use
11/10/1994	WO1994012649A3 Gene therapy for cystic fibrosis
11/10/1994	CA2161695A1 N-acyl substituted phenyl piperidines as bronchodilators and anti-inflammatory agents
11/10/1994	CA2161544A1 Cyclooxygenase and 5-lipoxygenase inhibiting n(3-biphenylyl- 1(s)-methyl-2-propenyl) acetohydroxamic acid derivatives
11/10/1994	CA2161216A1 Amidino and guanidino substituted boronic acid inhibitors of tryspin-like enzymes
11/10/1994	CA2161114A1 Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies
11/10/1994	CA2159990A1 2-,3-,4-,5-,6-,7-,8-,9-and/or 10-substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
11/10/1994	CA2159834A1 Thrombin inhibitors
11/10/1994	CA2139129A1 Peptidyl derivatives and their use as metalloproteinase inhibitors
11/09/1994	EP0623676A1 Metalloproteinase inhibitor
11/09/1994	EP0623627A1 Sulfonamide derivatives
11/09/1994	EP0623620A1 5-HT3 Pyrrolopyrazine derivatives
11/09/1994	EP0623615A1 Adhesion-receptor antagonists
11/09/1994	EP0623610A1 Substituted pyridines and 2-oxo-1,2-dihydropyridines as Angiotensine II antagonists
11/09/1994	EP0623607A1 Benzofuranyl-and-thiophenyl-alkanecarboxyclic acid derivatives
11/09/1994	EP0623606A2 Peptidic ketones as interleukin-1beta-converting enzyme inhibitors
11/09/1994	EP0623603A1 Styrene derivative and salts thereof
11/09/1994	EP0623596A1 N-acylpyrrolidines or N-acylpiperidines having a guanidinyl- or amidinyl-substituted side chain as thrombin inhibitors
11/09/1994	EP0623592A1 Peptide analogs as irreversible interleukin-1beta protease inhibitors
11/09/1994	EP0623347A1 Use of bisphosphoric acid derivatives for the manufacture of a medicament to improvement bone repair
11/09/1994	EP0623341A1 Use of 4-thioresorcin derivatives in skin whitening cosmetic or dermopharmaceutical compositions
11/09/1994	EP0623340A1 Use of hydroxy or dihydroxynaphthalene in the preparation of a cosmetic or dermatological composition for skin whitening
11/09/1994	EP0623339A1 Use of 4-,4- and 5-, or 4- and 6-substituted derivatives of resorcin in cosmetic or dermopharmaceutical compositions for depigmentation
11/09/1994	EP0623143A1 Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents
11/09/1994	EP0623134A1 Metal complexes of water soluble texaphyrins
11/09/1994	EP0623133A1 Substituted amino alkyl compounds
11/09/1994	EP0623126A1 Imidazole derivatives and their use as cytokine inhibitors
11/09/1994	EP0623120A1 Piperidineacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
11/09/1994	EP0623116A1 Amino acid derivatives as paf-receptor antagonists
11/09/1994	EP0616493A4 Methods and compositions for reducing multi-drug resistance.
11/09/1994	EP0570401B1 Lipoxygenase-inhibiting hydroxamic acid and n-hydroxyurea derivatives
11/09/1994	EP0533824B1 Piperidyl-substituted indoles
11/09/1994	EP0533820B1 Pharmaceutical preparation
11/09/1994	CN1094727A 5-arylindole derivatives
11/09/1994	CN1094724A 6-heterocyclic-4-amino1,3,4,5-tetrahydrobenzÛCDÙindoles for treating motion sickness and vomiting
11/09/1994	CN1094723A 羧酰胺衍生物 Carboxamide derivatives
11/09/1994	CN1094642A Therapeutic combination
11/09/1994	CN1094615A Compositions and method for providing improved analgesic effect
11/09/1994	CA2123050A1 Bile acid derivatives, processes for their preparation and the use of these compounds as medicaments
11/08/1994	US5362915 Inhibitors of enzymes/hydrolases; antiallergens, antiinflammatory agents
11/08/1994	US5362742 Quinoline derivatives, their production and use as ACAT inhibitors
11/08/1994	US5362740 Dihydrobenzofuran carboxamides and process for their preparation
11/08/1994	US5362734 Certain benzo-quinolizine compounds and derivatives thereof
11/08/1994	US5362733 Lipid peroxidation prevention
11/08/1994	US5362727 Treatment of cardiovascular disorders
11/08/1994	US5362641 Hydrolytic enzymes
11/08/1994	CA2123055A1 Peptidic ketones as interleukin-1 beta-converting enzyme inhibitors
11/08/1994	CA2122965A1 Substituted benzodioxines, process for their preparation and pharmaceutical compositions containing them
11/08/1994	CA2122960A1 Polycyclic compounds and processes for the preparation thereof
11/08/1994	CA1332944C Isoquinoline derivatives, their preparation and their use
11/08/1994	CA1332943C Process for preparing perhydrothiazepine derivatives
11/08/1994	CA1332941C N-alkylated quaternary nitrogen containing heterocycles
11/08/1994	CA1332940C N-alkylated quaternary nitrogen-containing heterocycles
11/08/1994	CA1332939C 2,5,6-substituted-n -alkylpyrimidines
11/08/1994	CA1332938C N-alkylated quaternary nitrogen-containing heterocycles
11/07/1994	CA2122789A1 Substituted pyridines and 2-oxo-1,2-dihydropyridines
11/07/1994	CA2122788A1 Benzofuranyl- and thiophenyl-alkanecarboxyclic acid derivatives
11/04/1994	CA2122646A1 Guanidinyl- or amidinyl-substituted methylamino heterocyclic thrombin inhibitors
11/04/1994	CA2095408A1 Method of combating acyclovir-resistant herpes simplex viral infections
11/02/1994	EP0622456A1 Prokaryotic and eukaryotic vectors producing polypeptides containing epitopes of PDGF B
11/02/1994	EP0622373A1 Phosphonic acid derivatives useful as anti-inflammatory agents
11/02/1994	EP0622361A1 Heterocyclic compounds as bradykinin antagonists
11/02/1994	EP0622358A1 Phenylglycinamides of 4-imidazolylmethyl-phenyl-acetic acids and their use against hypertension and atherosclerosis
11/02/1994	EP0622068A2 Hair restorer
11/02/1994	EP0621773A1 Formulation and use of carotenoids in treatment of cancer
11/02/1994	EP0584283A4 Osteoinductive protein mixtures and purification processes.
11/02/1994	EP0545972B1 Therapeutically active mixture of glutathion and anthocyan compounds
11/02/1994	CN1094446A ECK receptor ligands
11/02/1994	CN1094406A 3,3'-disubstituted-1,3-dihydro-2h-pyrroloÛ2,3-bÙheterocyclic-2-one useful in the treatment of cognitive disorders of man
11/01/1994	US5360925 Dual inhibitors of no synthase and cyclooxygenase, process for their preparation and therapeutical compositions containing them
11/01/1994	US5360820 Medical use for tachykinin antagonists
11/01/1994	US5360797 Bisphosphonic acid derivatives useful as anti-arthritic agents
11/01/1994	US5360735 DNA encoding a human 5-HT1F receptor, vectors, and host cells
11/01/1994	US5360616 Solid, nonporous microspheres of an injectable steroid
11/01/1994	CA1332839C 8-substituted quinoline derivatives and their use in therapy
11/01/1994	CA1332835C Aliphatic carboxamides
11/01/1994	CA1332808C Polyester-based composition for the controlled release of medicinal substances
10/1994
10/31/1994	CA2122290A1 Pyrrolopyrazinic compounds, methods for their preparation and pharmaceutical compositions containing them
10/30/1994	CA2122227A1 Peptide analogs as irreversible interleukin-1.beta. protease inhibitors
10/27/1994	WO1994024285A1 Macrophage inflammatory protein variants
10/27/1994	WO1994024151A1 1,5 benzodiazepine derivatives having cck and/or gastrin antagonistic activity
10/27/1994	WO1994024149A1 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity
10/27/1994	WO1994024143A1 Method of forming oligonucleotides
10/27/1994	WO1994024132A1 Tetrahydro-pyrido-indole

1 ... 1418 1419 1420 1421 1422 1423 1424 1425 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 ... 1564